Leading the way in stroke recovery. Kandu is revolutionizing stroke recovery. By combining brain activated therapy with personalized telehealth services, we deliver a first-of-its-kind solution that empowers stroke survivors and transforms outpatient stroke care. robotics, rehabilitation, PM&R, EEG, BCI, stroke, CVA, and neurology

67 similar entities Type: Startup Activities: healthtech deeptech Technologies: Affective Computing Robotics

Precision Delivery for the Next Generation of Biologics Portal Instruments is a privately held medical device company focused on developing and commercializing innovative drug delivery platform technologies that transform the administration of injectable medications. Portal's mission is to improve patient experience, adherence, and outcomes through advanced, user-centric delivery solutions. Chronic Disease, Digital Health, Disease Management Solutions, Medical Device, and Drug Delivery Device

104 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the …

61 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

a new wave of comfort and health. Wave Therapeutics, a Techstars company, has developed disruptive smart cushioning technology designed to prevent bedsores, save lives, and reduce a huge cost center for long-term and acute care facilities. Our devices help reduce the risks of bedsores and blood clots through a unique combination of tested medical therapies combined with powerful analytics capabilities. Using our technology healthcare facilities can reduce hospitalization stays and treatment costs, increase reimbursements, and eliminate crippling legal liabilities. Our technology is affordable, works better than anything else on the market, and has medical, consumer, and even military application with …

317 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up …

59 similar entities Tags: FrenchTech120 Type: Startup Activities: deeptech healthtech manufacturing nanotech Technologies: Synthetic Biology

Miravas is an innovative medical devices start up in varicose veins treatment Soon a new device for the treatment of venous disease in medical office setting, with combination of two complementary techniques, steam and radiofrequency Varicose veins treatment, Medical devices, and Thermal ablation

111 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Reinventing surgical suture Via its AnCore technology, COHESIVES develops medical devices intended to reinforce and seal surgical sutures. AnCore limits complications and increases surgeon confidence. Adhesive, suture, and wound dressing

94 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Targeted Enzyme Delivery to improve thrombolysis TargED started in September 2018 and is currently developing one biopharmaceutical product: MICROLYSE. MICROLYSE enzymatically breaks down blood clots in small blood vessels (i.e. the microvasculature), for which to date, no specific treatment exists. TargED pursues to receive market authorization for an orphan disease named Thrombotic Thrombocytopenic Purpura (TTP) that is characterized by life threatening attacks of microvascular thrombosis. However, MICROLYSE has the capacity to target all forms of microvascular thrombosis and could also be applied in early-stage macrovascular thrombosis as seen in heart attacks and stroke. Biologicals, Thrombolysis, and Microvascular thrombosis

58 similar entities Type: Startup Activities: deeptech biotech

Cloud Based Haematology Diagnostics Delivered aaS RheoDx is a diagnostics company committed to improving the quality of life of hematology patients and the efficiency in their clinical management. Develops an inexpensive medical device that monitors red blood cells conditions in less than five minutes with a drop. Its small size and simplicity allow to be used at the point-of-care and at home. Spin-off of the Centre Recerca Matemàtica (CRM), and incorporated in the Collider, the venture builder of tech transfer by Mobile World Capital Foundation. Medical Devices, In vitro diagnostics, Hematology, Point-of-care, Transfusions, and Blood cells conditions

202 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

GizmoMD: Where Tech Meets Healthcare Where Tech Meets Healthcare. We report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world. medical devices, medical discoveries, medical technology, conferences, medicine, events, and publishing

184 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Saving Lives Treating Brain Aneurysms - 'Origami Engineering' for the Brain Oxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage. OxiFlowTM️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. Competitors have adverse events related to poor placement of devices due to their inherent design weaknesses. OxiFlowTM️ is a unique design that places more accurately and safely than existing products, reducing risk of complications and conforms to blood vessel shapes making more patients treatable. Patented in Europe, US, China & Japan. Created …

53 similar entities Type: Startup Activities: deeptech

Simplifying diagnosis of microvascular disease in interventional cardiology Echopoint Medical is a fast-paced medical device start-up in London UK, a spin-out of the University College London. We develop, manufacture and commercialise cutting-edge cardiovascular devices with a bold vision to provide unprecedented sensing and imaging capabilities in minimally invasive procedures. Using breakthrough optical sensors and advanced algorithms, Echopoint Medical will significantly improve how patients with cardiovascular disease are treated, reducing cost and complications, and improving outcomes. The development team is composed of a small but diverse group of engineers, clinicians and management who strive to make a positive clinical impact. Medical, …

187 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

SCALJET has developed a brand new medical device, the 1st ever designed "Aero-Hydro dissector"​ SCALJET is a privately held MedTech company committed to providing surgeons with innovative new technology in both dissection and transection phase. SCALJET has developed a brand new medical device, the 1st ever designed "Aero-Hydro dissector"​ which can be either used as an Hydraulic dissector and also used as an Hydraulic scalpel, using micro jets of sterile physiological saline solution with low flow, with no limitation of applications, in all surgery types. ​ The innovation of SCALJET Aero-Hydro dissector is based on the creation of the “Blowing …

58 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Keep track of the heart. Everywhere. All the time. Vectorious Medical Technologies develops novel treatment for heart failure patients which is based on physician directed, patients’ self-management paradigm. Leveraging its advanced, first of its kind, implantable V-LAP platform, which harvests valuable information from the heart’s left atrium, physicians and patients can monitor and manage disease status, prevent hospitalizations and improve quality of life. The V-LAP system is an investigational device which is currently under evaluation in multiple clinical studies in Europe, Israel and the U.S. Medical Devices, Wireless communication, Miniature Implants, Heart Failure, Remote Monitoring, and Sensors

137 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Stent'Up vise à sécuriser le traitement préventif des anévrismes cérébraux par la création d'un implant révolutionnaire. Stent Up, designs, manufactures, and markets medical devices dedicated to the treatment of strokes.

75 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Neurotech & photomedicine REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia. MedTech, NeuroTech, Neurophonic, Photonics, …

198 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

JOIN THE FUTURE NOW! PrediSurge provides AI-driven Digital Twin simulations that assist vascular surgeons in planning their interventions with greater accuracy and empower device manufacturers with tailored digital solutions to optimize their products’ performance. Healthcare, Digital solutions, Numerical simulation, Decision support, Cardiovascular interventions, Digital twin, and Endovascular repair

70 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

At SCAP Hologram, we are committed to bringing disruptive navigation and extended reality solutions to shoulder surgery. We strive to innovate and make a difference in our surgeons and patient’s lives. Our heritage in digital surgery provides us with the knowledge to move forward - powered by experience and driven by innovation. Medical Device, Enabling Technologies, and Shoulder Surgery

132 similar entities Type: Startup Activities: healthtech deeptech Technologies: VR

Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation

187 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Building an AI neurologist to save the lives of stroke patients by providing better pre-CT diagnostics. Stroke is the 2nd leading cause of death and disability worldwide, and 25% of us will have at least 1 stroke in our lifetime. However, globally, fewer than 5% of acute ischemic stroke patients receive effective treatment within the critical 4-6 hour window for clinical intervention. The clinical signs of a stroke vary greatly from patient to patient as they depend on the specific area of the brain that is affected. Very often, the patient, relatives, and even emergency professionals do not understand that …

57 similar entities Type: Startup Activities: healthtech Technologies: A.I.

BCV Systems is an industrial medtech company operating at the intersection of engineering, medicine, and real-world clinical environments. We develop endovascular navigation systems powered by active mechatronic technology, designed for demanding procedures where precision, control, and reliability are critical. Our approach enables controlled navigation through complex vascular anatomies, with a strong focus on predictability and consistency in real use. Beyond performance, we focus on how technology integrates into clinical practice. Usability, reliability over time, and seamless interaction with evolving procedural environments, including robotic-assisted interventions, are central to our development. Founded in 2016 as a spin-off from the ISIR (Institut des …

170 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Robotics

LaNua Medical Limited is a MedTech company focused on developing solutions in the Embolization space for Interventional Radiologists worldwide. We are building our team and have exciting roles in R&D and Quality. Medical Devices and Embolization

203 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Pledged to save millions At SMT (Sahajanand Medical Technologies), we are revolutionizing healthcare through innovation and clinical excellence. As a multinational MedTech company with diversified manufacturing facilities and operations across multiple countries, SMT is at the forefront of high-end cardiovascular, endovascular, and structural heart devices. Guided by our mission, “Pledged to Save Millions,” we specialize in developing clinically proven solutions for coronary interventions, occluders for congenital defects, and structural heart therapies. Our products undergo rigorous clinical trials and are featured in world-class medical journals like The Lancet, New England Journal of Medicine, BMJ Open, and JACC, cementing our position as …

159 similar entities Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

SCALEO® Medical conceptualizes, develops and manufactures high-tech CE certified medical devices. Our goal is to build a successful and high technology company in the medical field, providing the best care and effective product solutions for the nursing staff and the patients. SCALEO Medical invents, develops and manufactures innovative products in the fields of patient transfer and hygiene, respiratory and medical weighing equipments. We are committed to helping our patients by developing safer and more effective products for more specialized care. We want to highlight quality products and references that will convince by their efficiency and reliability. We are committed to …

263 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients.

153 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Our medical device BraiN20 adresses the best management of Acute Ischemic Stroke | Neurology | Stroke | MedTech start-up AFTER A STROKE, TIME LOST IS BRAIN LOST​ 1.9M BRAIN CELLS DIE IN 1 MIN​ •The burden of the disease​ 15 million people suffer from stroke worldwide each year. ​ 1st cause of acquired disability​ 2nd leading cause of death​ •Why? The ineffective Acute Ischemic Stroke (AIS) management​ •Our solution​: BraiN20® A novel portable medical device​ The stroke ECG​ •Our key innovations​ Proprietary algorithm based in TiB research in real patients​ Taylored design and development adjusted to end-users requirements​ ​•Our benefits …

88 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Fighting chronic and fatal diseases Tirecat Health is a company developing a family of novel polymers with amazing potential in the healthcare field. We are propelled with purpose to fight chronic and fatal diseases affecting patients worldwide using our revolutionary technology to improve their quality of life. In order to make this purpose a reality, the company is preparing to move towards the clinical phase to demonstrate the astonishing results seen in preclinical trials.

300 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Sky Medical develops bioelectronic devices to treat a wide range of acute and chronic circulatory conditions. Sky Medical develops bioelectronic devices integrated with OnPulse neuromodulation technology to prevent and treat a wide range of acute and chronic circulatory conditions (e.g. to prevent venous thromboembolism (VTE), to prevention and reduction of edema after surgery, to heal venous and arterial leg ulcers as well as chronic wounds, and speed-up recovery time for high-performance athletes. After conducting further clinical research, OnPulse is now being used in hospitals and in community care centers to accelerate patient recovery after surgery and to accelerate healing of …

189 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases neurodegeneration, RNA therapeutics, physiological upregulation, post-transcriptional upregulation, mRNA, ASO, and SINEUP

209 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Neuromodulation Simplified Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body. The primary focus is on treatments for chronic pain. Neuromodulation, DRG, Chronic Pain, PNS, and Stimulation

193 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Enabling greater access to critical medical interventions through telerobotics Nanoflex Robotics is a spin out from ETH Zurich developing endoluminal soft robotic systems that can be remotely manipulated within the body. We're focused on Interventional Neuro Radiology procedures for the access to and treatment of Ischemic and Hemorrhagic stroke. Stroke, Medical Device, Neuro Radiology, Telemedicine, and Neuro Surgery

91 similar entities Type: Startup Activities: healthtech deeptech Technologies: Robotics

Full Cerebral Embolic Protection System to Reduce the Risk of Cerebrovascular Events during TAVR/ TAVI. Protembis is an Aachen, Germany based medical device startup. It develops a novel catheter-based filter device for use during cardiac interventions. The device is designed to minimize the risk of stroke and other neurological injury during these interventions – particularly during transcatheter aortic valve replacement procedures (TAVR/ TAVI). The filter blocks embolic debris from entering the blood vessels leading to the brain. The initial safety and feasibility of the ProtEmbo® device has been demonstrated in a first-in-human study in 2017/ 2018. The imaging data of …

70 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

A New Hope for Hemorrhagic Stroke Op2Lysis develops new treatments for patients suffering from thrombosis at the cerebrovascular level, with an initial focus on the hemorrhagic form of stroke. Indeed, there is no currently approved and available therapeutic solution for these patients. The company develops its game-changing NANOp2Lysis platform, associating a breakthrough vectorisation technology, industrial know-how enabling clinical quality production, and preclinical expertise to propose predictive and translational models, a first in this field. O2L-001, the first product resulting from this technology, will soon enter regulatory toxicology with the aim of applying for clinical trial authorisation in patients in North …

234 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Join our community of healthcare professionals: https://www.linkedin.com/groups/12920054/ Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription Medical …

443 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The smart choice for healthy veins UK Vein Clinic is a team of leading vascular surgeons and specialist practitioners providing high quality outcomes for minimally invasive varicose veins treatment. Vascular , Vascular Treatment, and Varicose Vein Treatment

56 similar entities Type: SMB Activities: healthtech

We bring greater accuracy and safety to high-risk surgical procedures We make cardiovascular surgeries safer. We're developing a software platform that provides an unprecedented and truly unique visibility in cutting-edge keyhole surgeries. We allow surgeons to see what is happening inside blood vessels in real time, how devices interact with arterial walls, and travel through tissues and bones. Our PreSize Stenting serves as a planning tool that enables surgeons to rehearse procedures and select the optimal scenario for a given patient, reducing complication rate and associated costs. Maybe you've heard of us already? - WIRED UK "Best Healthcare Startup of …

160 similar entities Type: SMB Activities: healthtech Technologies: SaaS

Transformative vascular implants. Addressing major life-threatening diseases, backed by Nobel-winning science. Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. www.xeltis.com

95 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

We’re EnovisTM – a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes and restore motion for life. We strive to make each day better by partnering with the brightest minds in health to advance care that is smarter, personalized, and more effective, while improving operational efficiency for surgeons and clinicians around the world. We do this through our extraordinary talent, a laser focus on innovation, strategic acquisitions, and a common culture of continuous improvement. With more than 7,000 incredible employees worldwide and an extensive range of products, services, and integrated technologies …

232 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Vascular health monitoring make sense. Soigner avec le code, en codant avec soin. Research and development of software and vascular-oriented medical device. Translational research for B2B partners in vascular signal and imaging field. medtech, e-health, e-santé, volumétrie, and samd

101 similar entities Type: Startup Activities: healthtech deeptech Technologies: SaaS

Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology

337 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Facing the global challenge of the lack of heart grafts, PROCOPE Medicals develops an innovative total artificial heart Thousands of people die every year of severe heart failure, due to the lack of donors, heart transplant is increasingly rare : 3% of patients receive a donor heart. PROCOPE Medicals acts and develops a new generation of artificial heart.

59 similar entities Type: Startup Activities: healthtech deeptech

Pioneering Next-Generation Stroke Treatments 👉Funding round is still open: https://capitalcell.com/campaign/freeox/ FreeOx Biotech: Advancing Stroke Care through Innovation and Precision Medicine FreeOx Biotech is a pioneering late-stage clinical biotechnology company dedicated to transforming acute ischemic stroke (AIS) management. Our mission is to improve outcomes for stroke patients through the discovery and development of Cerebrovascular Protective Therapeutics. Our lead asset, Ox-01, is a Phase 3-ready investigational drug with breakthrough potential as an emergency adjunct therapy to Mechanical Thrombectomy. Selected by the prestigious StrokeNet Thrombectomy Endovascular Platform (STEP) program, funded by the National Institute of Neurological Disorders and Stroke (NINDS), Ox-01 represents a …

63 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

At Medartis, we develop, manufacture and distribute titanium screws and plates, surgical instruments and system solutions for fracture fixation. Headquartered in Basel, Switzerland, our company is represented worldwide through 12 subsidiaries and a wide distributor network. We place the highest priority on maintaining stringent quality standards, continuous development and innovation, including comprehensive service provision for physicians, operating-room (OR) staff and patients. Our long-term customer relations based on partnerships have formed the foundation for our sustainable success since the company’s founding. Dr. h.c. Thomas Straumann founded Medartis in 1997 and returned to the field of osteosynthesis in cranio-maxillofacial surgery. Our product …

236 similar entities Type: SMB Activities: deeptech healthtech Technologies: Decarbonization

Innovating Medical Devices Inomed Health Limited is a UK distributor of innovative medical implantable and disposable devices to the NHS and private healthcare institutions. We are a focused company supporting customers and manufacturers to constantly improve the way surgical and non-surgical treatments are performed, delivered through better medical technology to improve the lives of patients. Medical Devices, Interventional Radiology, Biopsy Devices, and Bariatric Health & General Surgery

411 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Denmark-based group of companies focused on production and distribution of OTC CBD medical devices and cosmetics. CS MEDICA is a group of two fully-owned, Denmark-based subsidiaries: Galaxa Pharma A/S and CanNordic A/S, whereby CanNordic A/S is a registered Medical Device product developer and Galaxa Pharma A/S is product distributor in the Nordic Region. We see ourselves as a company in constant development, exploring the ways in which we can support patients in their battle against the disease, the pain and the sorrow it brings. Medical Device, Pharmaceuticals, Cosmetics, Regulatory Affairs, Distribution, Manufacturing, Cannabinoids, and CBD

230 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Accessible innovation designed to improve patient outcomes Yorkshire based Med Tech company specialising in Orthopaedics. A small company planning on making a big impact ! Orthopaedics, Medical Devices, and Innovation

314 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Advancing the Treatment of Intracranial Atherosclerotic Disease (ICAD) CeroFlo is pioneering a next-generation intracranial stent for Intracranial Atherosclerotic Disease (ICAD), the most urgent and underserved market segment of stroke..

58 similar entities Type: Startup Activities: deeptech biotech

PerQseal® Elite - Minimal Vascular Complications – Consistently Secure Closure Now a part of Haemonetics, Vivasure Medical Ltd. is an ISO 13485 registered medical device company based at Europe’s leading MedTech cluster in Galway, Ireland. Founded in 2009, the company is led by an experienced management team and backed by a syndicate of international venture capital investors and state agencies. The company has developed and patented the world’s first fully absorbable, patch-based closure device specifically designed to seal large-bore arteriotomies in endovascular procedures. Please, refer to our website for further information. Medical Device, Vascular Closure, Design & Development, ISO 13485, …

335 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

We are Balt. Physician-inspired innovations. Patient-focused solutions. For more than 45 years, Balt has been leading the way – collaborating with physicians and institutions to develop elegant neurovascular solutions. As the premier global neurovascular platform, always seeking to expand beyond boundaries, we are now bringing our innovation to the peripheral vascular space. We introduced the first neurovascular intervention device in 1977. Now, we offer the world’s broadest portfolio of medical devices for ischemic and hemorrhagic stroke, as well as devices for peripheral embolization. In 2015, we embarked on an ambitious journey and more than quintupled our revenue and workforce, and …

187 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Enabling a new standard of care to fight stroke and save lives Artiria Medical empowers catheters and guidewires. We develop cutting edge technologies to bring micromotion deep in the brain arteries, enabling a seamless navigation and stroke treatment. ARTIRIA comprises a passionate team willing to bring a new standard of care to stroke surgeons for the benefit of their patients.

60 similar entities Type: Startup Activities: healthtech deeptech

CorFlow is developing a system that will be the first to detect & treat microvascular obstruction (MVO) in real time. CorFlow was founded on the belief that current PCI and cardiac care remains suboptimal due the fact that underlying microvascular dysfunction and obstruction is not detected and treated adequately. CorFlow believes, like much of the medical community, that the next frontier of innovation and positive impact on clinical outcomes in cardiology and beyond will come from the microvascular space. Our first solution is a system that will be the first to diagnose microvascular obstruction (MVO) in real time during PCI …

121 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

We are a biopharmaceutical company dedicated to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other.

284 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Creator of Sonovein®: The Only Non-Invasive Varicose Vein Treatment Theraclion is the French MedTech company behind the Sonovein®, the only non-invasive varicose vein treatment. Robotic-driven, Sonovein® is powered by High Intensity Focused Ultrasound (HIFU). It does not require incisions nor an operating room, leaves no scars, and allows patients a quick return to their daily activities. The CE-marked platform has the potential to replace millions of surgical procedures every year. In the United States, Sonovein® is an investigational device limited to investigational use; it is not available for sale in the U.S. Based in Malakoff (Paris), the Theraclion team is …

169 similar entities Type: SMB Activities: healthtech deeptech Technologies: Robotics Synthetic Biology

Cerapedics is a global orthopedics company dedicated to redefining the path to bone repair. Cerapedics is a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair by healing bones faster and at higher rates, so all patients can get back to living their fullest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma, and interventional procedures worldwide. Cerapedics has two drug-device products approved by the FDA powered by Cerapedics’ proprietary P-15 Osteogenic Cell Binding Peptide: PearlMatrixTM Bone Graft for all major lumbar interbody surgical approaches and i-FACTOR® Bone Graft for …

50 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics

Transforming Energy into Therapy Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. medical device, COPD, AF, Oncology, Intervential Oncology, Intervential Pulmonology, AFib, PEF, PEF Ablation, Soft Tissue Ablation, Cardiac Arrhythmias, and Chronic Bronchitis

451 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Recor Medical, headquartered in Palo Alto, Calif., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise system is FDA approved in the United States, bears the CE mark, and is an investigational device in Japan, hypertension, medical device, and Intervention cardiology

99 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Designing & commercializing medical devices for all healthcare ecosystems. Sisu Global develops patented, cutting-edge, world-class medical devices that are designed to save lives, enable patient access to care and increase resources for healthcare ecosystems. Our medical device, Hemafuse, is a highly effective, mechanical alternative to donor blood and available in Ghana, Kenya, India, and Tanzania. Hemafuse increases access to blood by enabling clinicians to capture a patient’s blood, filter it, and return fresh, whole blood back to that same patient. Hemafuse provides immediate access to blood transfusion across trauma, obstetric, general, and orthopedic surgeries with internal bleeding. We have raised …

77 similar entities Type: Startup Activities: deeptech civictech healthtech Technologies: Synthetic Biology

Portfolio of transcatheter & endovascular anchoring solutions Endoron Medical portfolio of anchoring solutions expands and enhances treatment for patients by making current devices better across the aortic continuum from TAVR to EVAR. Aortodock was developed as a transcatheter valve docking solution for calcium- and leaflet-independent anchoring and stability, enhancing procedural predictability and reliability, expanding treatment options for vascular heart disease Aortoseal was developed to mimic the reliable hand-sewn suturing technique from open surgery, evenly distributing staples around the circumference of the aorta, creating leak and migration free anastomosis. Endoron is a proud beneficiary of the EIC grant. The European Innovation …

48 similar entities Type: Startup Activities: deeptech

We make hemodialysis portable. Nextkidney’s mission is to develop and commercialize the Neokidney home hemodialysis device. Placing the patient and his quality of life at the center of its approach, the company uses innovative technologies to offer a safe, practical and easy-to-use solution as quickly and widely as possible throughout the world. medical device, Manufacturing , Dialysis, and Home Dialysis

123 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

Developing novel medications for patients with atrial fibrillation InCarda Therapeutics is a privately held biotechnology company backed by leading VC investors, Deerfield Management and HealthCap, developing novel drugs for the treatment of patients with atrial fibrillation (“AF”). Our mission is to enable rapid restoration of normal sinus rhythm ("NSR") with therapies designed to be fast-acting, safe, simple to use, and available across the continuum of care—from hospital-based cardioversion to at-home, self-administered treatment. Cardiovascular, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Clinical Research, Pre-Clinical Research, atrial fibrillation, and arrhythmias

127 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Excellence for Life BIOTRONIK is a global medical device company providing products and services for the treatment of cardiovascular and endovascular diseases. Patient well-being is our main priority. For 60 years, we have been driven by the desire to save lives and improve the quality of life of patients. With thousands of employees in more than 100 countries, we are among the world's leading medical technology innovators in the areas of cardiac rhythm management, electrophysiology and vascular intervention. Our technology empowers doctors around the world to provide their patients with the best possible healthcare. Heart rate management Implantable devices help …

140 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Contract medical device development in cardiovascular and minimally invasive surgery. Thanks to the experience and global vision that we bring to the development projects of minimally invasive surgery and cardiovascular devices, we propose a global project architecture offering the key to success to the bearers. By creating favorable conditions for innovation, especially through the animation of a multidisciplinary hub of specialists, we help to advance care and their consequences with rigor and creativity. We are committed alongside our clients to bring their vision and ambition to life. R&D, design, medical device, testing, manufacturing, regulatory compliance, cardiovascular, and minimally invasive

272 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

NEXT GENERATION THROMBECTOMY SYSTEMS Anaconda Biomed S.L. is a Barcelona based medical device start-up co-founded by Dr. Marc Ribo and Dr. Ofir Arad. The company is developing the next generation of catheters to perform safe and efficient mechanical thrombectomies. Health, Innovation, Medical Devices, Stroke, Thrombectomy, and Medical Technology

160 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

In February of 2025, Stryker acquired Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases. Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

249 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

The new tool of hand, wrist, and fingers rehabilitation through a tablet device ReHand is a hand rehabilitation app that qualifies as a Class I medical device. hand therapy, terapia de mano, telerehabitation, and telerehabilitación

78 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

miRNA-enhanced Extracellular Vesicles Therapeutics ConvEyXO, founded in 2019 by veterans of pharma industry, builds a specialized technology platform to convey exosome-based therapeutics to the market. The company is developing is therapeutic portfolio in the field of fibrosis and chronic inflammatory disorders. The rapid development of the company is the result of collaborations with partners with a demonstrated track record in healthtech and biotech fields manufacturing, process development, upstream, downstream, extracellular vesicles, exosomes, therapeutics, cargo, Loading, 4D, and exosomes

444 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Improving the lives of stroke victims by developing tools for early and accurate neurologic assessment. Forest Devices is a medical device startup located in Pittsburgh, Pennsylvania. We are the creators of SignalNED, a fast, reliable, and accurate rapid EEG providing users clear qEEG results. Our mission is to create a better way to detect stroke and make informed decisions that directly lead to an improved quality of life for patients post-stroke and a decreased burden to the healthcare system and patient’s loved ones. Medical Devices

70 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Lumix Laser - Cutting-edge technology - Unique, powerful & versatile Exclusive French distributor for FISIOLINE. Cutting-edge technologies and effective therapeutic protocols for results from the first session. Medical Device, Laser, and Surgery

306 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Engineering Stroke Solutions ENGINEERING Stroke Solutions Acandis, founded in 2006, is a privately held German medical device company focused on the prevention and treatment of stroke. We have a passion for technology and our engineers are enthusiastic about creating solutions for unmet clinical needs to improve patient’s lives. We strive towards a comprehensive device portfolio and continuous development of products and services to improve stroke care for neurointerventionalists around the globe. The safety of our products has been demonstrated on the bench top and now the efficacy of those products is being proven in clinical trials. As a company we …

296 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Helping you achieve positive outcomes for your patients The world needs you at your best, so we create breakthrough solutions that help you save valuable time and restore patients' lives. Medical products and solutions, Dental and orthodontic supplies, and Health information solutions

296 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

"Simplicity, the ultimate sophistication" (Leonardo da Vinci) X-Bolt brings simplicity and efficiency to trauma surgery, whilst improving quality of life for patients. surgery, orthopedics, medical devices, distribution, hip trauma, sales, marketing, and design

232 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Unlocking life-saving stroke treatments by leveraging AI on the simplest imaging methods Methinks AI is redefining stroke care through fast, accessible, and scalable AI-driven imaging. We specialize in non-contrast CT (NCCT) — the most widely available imaging — to detect large vessel occlusions and intracerebral hemorrhages, enabling earlier triage and faster treatment decisions. Integrated into Microsoft Teams and in partnership with Microsoft, Methinks is built for clinical coordination and technical scalability. Our solution is CE-marked, validated in top hospitals across Europe and the U.S., and is transforming stroke pathways in both high- and low-resource settings. A VC-backed, commercial-stage company, Methinks …

69 similar entities Type: Startup Activities: healthtech Technologies: A.I. A.I. - Deep Learning